Review: taking Fluoxetine hydrochloride and Nabumetone together


Summary

Drug interactions are reported among people who take Fluoxetine hydrochloride and Nabumetone together. This review analyzes the effectiveness and drug interactions between Fluoxetine hydrochloride and Nabumetone. It is created by eHealthMe based on reports of 439 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Fluoxetine hydrochloride and Nabumetone >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Fluoxetine Hydrochloride

Fluoxetine hydrochloride has active ingredients of fluoxetine hydrochloride. It is often used in depression. (latest outcomes from Fluoxetine hydrochloride 4,644 users)

Nabumetone

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. (latest outcomes from Nabumetone 4,466 users)

On Aug, 24, 2016

439 people who take Fluoxetine Hydrochloride, Nabumetone are studied.


Number of reports submitted per year:

Fluoxetine hydrochloride and Nabumetone drug interactions.

Drug effectiveness over time:

Fluoxetine Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 75.0% - (3 of 4 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)
Nabumetone:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Fluoxetine Hydrochloride:
  • female: 50.0% - (4 of 8 people)
  • male: 75.0% - (3 of 4 people)
Nabumetone:
  • female: 37.0% - (3 of 8 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Fluoxetine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 66.0% - (4 of 6 people)
  • 50-59: 66.0% - (2 of 3 people)
  • 60+: 0.0% - (0 of 1 people)
Nabumetone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • pruritus
  • cardiac failure congestive
  • dermatitis
  • dermatitis contact
  • dermatitis exfoliative
  • drug eruption
  • dyspnoea
  • emotional distress
  • excoriation
  • eye oedema
1 - 6 months:
  • dysphagia
  • lip oedema
  • mucosal erosion
  • oral pain
  • rash maculo-papular
  • chronic pain
  • conjunctival erosion
  • conjunctival ulcer
  • conjunctivitis
  • dysuria
6 - 12 months:
  • hepatic congestion
  • pain
  • pulmonary congestion
  • drug toxicity
  • hyperhidrosis
1 - 2 years:
  • pain
  • death
  • hepatic congestion
  • pulmonary congestion
  • unresponsive to stimuli
  • depressed level of consciousness
  • arteriosclerosis coronary artery
  • body temperature fluctuation
  • drug toxicity
  • esophageal spasm
2 - 5 years:
  • breast microcalcification
  • cerebrovascular accident
  • colitis
  • emotional distress
  • fall
  • generalised anxiety disorder
  • hypertension
  • intestinal haemorrhage
  • lymphadenopathy
  • oedema peripheral
5 - 10 years:
  • bladder spasm
  • pneumonia
10+ years:
  • barrett's oesophagus
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • constipation
  • depression
  • dyspnoea
  • heart rate irregular
  • loss of consciousness
  • micturition disorder
  • musculoskeletal chest pain
not specified:
  • fall
  • pain
  • anxiety
  • dysphagia
  • back pain
  • depression
  • anaemia
  • ear pain
  • injury
  • arthralgia

Most common drug interactions by gender *:

female:
  • fall
  • pain
  • dysphagia
  • anxiety
  • ear pain
  • back pain
  • injury
  • spinal osteoarthritis
  • anaemia
  • oedema peripheral
male:
  • pain
  • depression
  • anxiety
  • fall
  • nausea
  • drug dependence
  • drug withdrawal syndrome
  • back pain
  • insomnia
  • chest pain

Most common drug interactions by age *:

10-19:
  • juvenile arthritis
  • spondylitis
20-29:
  • pain
  • pulmonary embolism
  • vomiting
  • abdominal discomfort
  • abdominal distension
  • abdominal pain
  • activities of daily living impaired
  • akathisia
  • anxiety
  • asthenia
30-39:
  • nausea
  • back pain
  • agitation
  • depression
  • drug dependence
  • drug withdrawal syndrome
  • fall
  • insomnia
  • anxiety
  • drug ineffective
40-49:
  • myocardial infarction
  • deep vein thrombosis
  • depression
  • hypertension
  • benign hepatic neoplasm
  • cerebral haemorrhage
  • cerebral thrombosis
  • embolism arterial
  • gallbladder disorder
  • hepatic adenoma
50-59:
  • pain
  • dyspnoea
  • fall
  • diarrhoea
  • nausea
  • vomiting
  • death
  • headache
  • anxiety
  • sleep disorder
60+:
  • fall
  • dysphagia
  • pain
  • back pain
  • spinal osteoarthritis
  • ear pain
  • injury
  • anaemia
  • osteoarthritis
  • pain in jaw

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Fluoxetine hydrochloride and Nabumetone?

Can you answer these questions?

More questions for: Fluoxetine hydrochloride, Nabumetone

You may be interested in these reviews

More reviews for: Fluoxetine hydrochloride, Nabumetone

On eHealthMe, Fluoxetine hydrochloride (fluoxetine hydrochloride) is often used to treat depression. Nabumetone (nabumetone) is often used to treat arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.